The AlphaLISA™ SureFire® Ultra™ Human Phospho-ULK1 (Ser556) assay is a sandwich immunoassay for quantitative detection of phospho-ULK1 (Ser556) in cellular lysates using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human Phospho-ULK1 (Ser556) assay is a sandwich immunoassay for quantitative detection of phospho-ULK1 (Ser556) in cellular lysates using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
UNC-51 like autophagy activating kinase exists in two similar isoforms, ULK1 and ULK2. ULK1 is regulated by the key nutrient/energy-sensitive kinases mTOR and AMPK, which are both able to phosphorylate ULK1 and directly regulate its kinase activity. ULK1 forms a complex with the Atg13 and FIP200 proteins, this complex is the most upstream component of the core autophagy machinery and is, therefore, the key initiator of autophagy in mammalian cells. ULK1 is implicated in a variety of therapeutic areas including oncology, autoimmunity, neurology, and diabetes.
The AlphaLISA SureFire Human Phospho-ULK1 (Ser556) Detection Kit is a sandwich immunoassay for the quantitative detection of phospho-ULK1 (Ser556) in cellular lysates, using Alpha Technology.
Application |
Cell Signaling
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Modality |
Alpha
|
Lysis Buffer Compatibility |
Lysis Buffer
|
Molecular Modification |
Phosphorylation
|
Product Group |
Kit
|
Sample Volume |
10 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
ULK1
|
Target Class |
Phosphoproteins
|
Target Species |
Human
|
Technology |
Alpha
|
Therapeutic Area |
Autoimmunity
Immuno-oncology
Metabolic
Neuroscience
Oncology
|
Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s, are complex disorders that affect millions...
Targeted protein degradation (TPD) offers a promising approach for treating neurodegenerative diseases by selectively degrading...
We are here to answer your questions.